HAVCR2 and neoplasm: In this study, to investigate Tim-3 expression on T cells after PD-1 blockade, we divided the mice (in the Anchored GM-CSF vaccine+anti-PD-1 antibody group) into sensitive and resistant groups according to the change in tumor size.